Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews Neuroscience
Nature Cell Biology
Nature Medicine
Neuroscience Gateway
UCSD-Nature Signaling Gateway
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Neuroscience 9, 917 - 924 (2006)
Published online: 18 June 2006; Corrected online: 18 June 2006 | doi:10.1038/nn1715

Control of microglial neurotoxicity by the fractalkine receptor

Astrid E Cardona1, Erik P Pioro1, Margaret E Sasse1, Volodymyr Kostenko1, Sandra M Cardona1, Ineke M Dijkstra1, DeRen Huang1, Grahame Kidd1, Stephen Dombrowski2, RanJan Dutta1, Jar-Chi Lee3, Donald N Cook4, Steffen Jung5, 6, Sergio A Lira7, Dan R Littman6 & Richard M Ransohoff1

1  Neuroinflammation Research Center and Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.

2  Department of Neurosurgery, Cleveland Clinic, Cleveland, Ohio 44195, USA.

3  Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio 44195, USA.

4  National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA.

5  Department of Immunology, Weizman Institute of Science, Rehovot 76100, Israel.

6  Howard Hughes Medical Institute and Skirball Institute for Biomolecular Medicine, New York University School of Medicine, New York, New York 10016, USA.

7  Immunobiology Center, Mount Sinai School of Medicine, New York, New York 10029, USA.

Correspondence should be addressed to Richard M Ransohoff ransohr@ccf.org

Microglia, the resident inflammatory cells of the CNS, are the only CNS cells that express the fractalkine receptor (CX3CR1). Using three different in vivo models, we show that CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity. Following peripheral lipopolysaccharide injections, Cx3cr1 -/- mice showed cell-autonomous microglial neurotoxicity. In a toxic model of Parkinson disease and a transgenic model of amyotrophic lateral sclerosis, Cx3cr1-/- mice showed more extensive neuronal cell loss than Cx3cr1+ littermate controls. Augmenting CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists could increase neuronal vulnerability.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Fractalkine: moving from chemotaxis to neuroprotection

Nature Neuroscience News and Views (01 Jul 2006)

ALS: life and death in a bad neighborhood

Nature Medicine News and Views (01 Aug 2006)

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
rights and permissionsRights and permissions
Order commercial reprintsOrder commercial reprints
CrossRef lists 46 articles citing this articleCrossRef lists 46 articles citing this article
Save this linkSave this link
Figures & Tables
Supplementary info
See also: News and Views by Bérangère Ré & Przedborski
Export citation

Open Innovation Challenges

naturejobs

natureproducts

Search buyers guide:

 
Nature Neuroscience
ISSN: 1097-6256
EISSN: 1546-1726
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2006 Nature Publishing Group | Privacy policy